LAUNXP Biomedical Co., Ltd (TPEX:6876)
Taiwan · Delayed Price · Currency is TWD 15.90
-0.15 (-0.93%)
Jul 17, 2026, 1:28 PM CST
LAUNXP Biomedical Market Cap
LAUNXP Biomedical has a market cap or net worth of 516.03 million as of July 17, 2026. Its market cap has decreased by -36.90% in one year.
Market Cap
516.03M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
15.90
ChartMarket Cap Chart
Since January 18, 2024, LAUNXP Biomedical's market cap has decreased from 721.03M to 516.03M, a decrease of -28.43%. That is a compound annual growth rate of -12.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 516.03M | -32.05% |
| Dec 31, 2025 | 759.44M | 11.55% |
| Dec 31, 2024 | 680.79M | -5.58% |
| Jan 18, 2024 | 721.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Meribank Biotech | 938.65M |
| TCI GENE | 922.08M |
| Taiwan Advance Bio-Pharmaceutical | 899.10M |
| NatureWise Biotech & Medicals | 832.30M |
| BioLASCO Taiwan | 781.17M |
| Neith | 710.20M |
| MegaPro Biomedical | 692.51M |
| Vectorite Biomedical | 669.70M |